In the RUTH study, leg cramps were observed in 12.1% of raloxifene-treated patients and 8.3% of placebo-treated patients.
RUTH uuringus vaadeldi jalakrampe 12, 1% raloksifeeniga ravitud patsientidel ja 8, 3% platseeboga ravitud patsientidel.